PUBLICATIONS REPRESENT SCHOLARSHIP, defined in Webster's Unabridged Dictionary as the "systematized knowledge of a learned person, exhibiting accuracy, critical ability and thoughtfulness." I believe publishing is extremely important because it contributes to the progress of a discipline, and to personal growth so that one may become a better teacher, practitioner, and researcher. We should regard it as a professional responsibility because the generation of new knowledge is essential for meeting the current and future needs of our society.
It has been said that "when a system of higher education only teaches, it risks becoming profoundly obsolete," And yet, two surveys of faculty publishing efforts have revealed disappointing figures: 60 percent of all college faculty have never published alone or in collaboration," and 50 percent of all pharmacy faculty published no papers in a five-year period." Similar recent data for pharmacy faculty or clinical pharmacy faculty, in particular, are not available.
Extensive guidance on how to write an article is available in journal articles and textbooks. In this editorial I will highlight common problems with articles submitted for publication to various biomedical and pharmaceutical journals; my intent is to assist pharmacy students, residents, and fellows.
In an original paper, sections may include introduction, background, rationale, hypothesis, objective, methodology, results, discussion, conclusion(s), and summary, and problems can arise in any of these sections. The introduction and background sections of one's article may not provide adequate rationale for doing a study or for writing a review or case report. "It has not been done or reported before" is not an adequate reason for doing something. The investigator should question the need for any study and/or article prior to undertaking the effort, even to the point of considering that perhaps it has not been done because it is not worth doing. implications for patient care. Many papers do not describe hypotheses and objectives specifically enough, thus leading to confusion on the part of the reader. Unless the hypothesis and objectives of a study are clearly stated the results cannot be shown to support or disprove the hypothesis and the conduct of the work cannot be shown to address the objectives.
The methods section of the paper is often too brief. This is the most important part of an original or research article. The readers should have all the details so that the findings can be reproduced and incorporated into their practice. A simple statement such as, "The drug was administered intravenously," may not be sufficient as there are so many ways of giving drugs by an intravenous route. Furthermore, the author should ensure complete delivery of drug doses by their method. Many authors indicate that a previously published analytical method was used to conduct their study, but leave out important details about sample preparation, modification of the original method, and coefficient of variation in the hands of the investigator. One of the most common problems is inadequacy of sample size (e.g., number of experiments run per observation or number of subjects studied). This limitation should be considered when analyzing data, interpreting results, and making conclusions.
The data analysis is frequently unclear and the reasons for using certain methods to analyze the data are not provided. There is also a tendency to lump the data in one group rather than to examine them after stratification.
Results may be presented as a summary of the findings. It is helpful if the unusual results (i.e., outliers) are presented with sufficient background information. These details are essential to a clear understanding of unexpected findings.
It is not uncommon for authors to make broad claims based on limited data. In such cases, the conclusions are not supported by the facts. Too often, specific dosage guidelines are proposed based only on pharmacokinetic characteristics of drugs in fewer than ten patients. Some authors have recommended routine monitoring of serum concentrations simply based on pharmacokinetic variability in a small group of patients. A relationship must exist between serum concentrations and efficacy or adverse effects before such monitoring can be justified.
A common pitfall of papers dealing with an assessment of drug stability is lack of documentation for using a stability-indicating analytical method. Before a method can be used for such studies, it must be determined that the degradation products generated by subjecting samples to extreme changes in temperature or pH must not interfere with the drug(s) under study. Otherwise, one can incorrectly conclude that the drug is stable when it is not.
Some may undertake to write a review article or to report a seemingly interesting case without sufficient consideration of existing literature. A critical examination of available literature is essential to identify the uniqueness of a new submission. Furthermore, a review article should clearly indicate unresolved and controversial issues, as determined by a careful review of published information, and should make optimal recommendations based on the various limitations of the available studies.
After an article has been written it should be reviewed by colleagues within or outside of the author's institution. An honest opinion about the worthiness of the paper should be sought. The article should be revised based on the colleagues' comments and then submitted to a refereed and indexed journal. It may take four to eight weeks to receive a response from the journal editor, during which time one or more reviewers will be examining the manuscript for acceptability for publication. When the reviewers' comments are sent, the author should take them in a constructive manner and revise the paper accordingly. In the event of a disagreement with the referee, the author can contact the editor and address such concerns. One may have to be persistent and patient for several months before the paper appears in print.
Much has been written about authorship, that is, whose names appear as author. This decision should be made during the planning stage of a study or a review article. Coauthor status is justified only when the work could not be done without the coauthor and when the coauthor can defend the work. The assistance of others should be acknowledged.
The possibility of restriction on publication must be considered. A funding agency may not wish to see negative findings published. Similarly, an institution may restrict publication of an article describing quality assurance or drug administration error problems. Every effort should be made to convince these parties of the importance of sharing one's experience with others to avoid future problems.
The bottom line for any published item is its quality. What impact did an article have on explaining unknowns, thereby improving patient care? The significance of a published clinical pharmacy article can be measured in various ways, including number and quality of citations, and by its incorporation into the standard of patient care. Careful attention to the details of manuscript preparation will ensure a higher level of quality for the final published product. It should also be remembered that published work undergoes a close scrutiny by peers living around the world not only when it first appears in print but for many years to follow.
Sir Francis Darwin has said, " ... in Science the credit goes to the man who convinces the world, not to the man to whom the idea first comes." I believe that published articles are the best means to convince the world of the importance of our work.
